Žofia Chrienová

605 citations
13 papers · 430 indexed · h-index 10
Topics
Computational Drug Discovery Methods (4 papers)Cholinesterase and Neurodegenerative Diseases (4 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)
Partner nations
CzechiaChinaSaudi Arabia

In The Last Decade

Žofia Chrienová

13 papers receiving 424 citations

Peers

Žofia Chrienová
Comparison fields: 5 of 94
  • Molecular Biology 158
  • Plant Science 148
  • Pollution 52
  • Physiology 42
  • Cancer Research 40
Replace Salwa Abid‐Essefi with:
Salwa Abid‐Essefi Tunisia
Hye-Won Lim South Korea
Mona M. Ahmed Egypt
Meimei Wang China
Mingyang Fu China
Yunzhou Li China
Yasumune Nakayama Japan
Yilong Cui China
Žofia Chrienová relative to Salwa Abid‐Essefi Tunisia Salwa Abid‐Essefi's profile →
Citations per field
00.5×1.5×2.2×
Salwa Abid‐Essefi · 1×
Citations per year

Countries citing papers authored by Žofia Chrienová

Since Specialization
Citations

This map shows the geographic impact of Žofia Chrienová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Žofia Chrienová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Žofia Chrienová more than expected).

Fields of papers citing papers by Žofia Chrienová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Žofia Chrienová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Žofia Chrienová. The network helps show where Žofia Chrienová may publish in the future.

Co-authorship network of co-authors of Žofia Chrienová

This figure shows the co-authorship network connecting the top 25 collaborators of Žofia Chrienová. A scholar is included among the top collaborators of Žofia Chrienová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Žofia Chrienová. Žofia Chrienová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 8
2 18
3 9
4 79
5 30
6 13
7 1
8 47
9 58
10 67
11 78
12 8
13 14

About Žofia Chrienová

Žofia Chrienová is a scholar working on Geriatrics and Gerontology, Computational Theory and Mathematics and Pharmacology, having authored 13 papers that have together received 430 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Pollution (52 citations), Plant Science (148 citations) and Aging (7 citations). Žofia Chrienová has collaborated with scholars based in Czechia, China and Saudi Arabia. Frequent co-authors include Eugenie Nepovimová, Kamil Kuča, Patrik Olekšák, Wenda Wu, Qinghua Wu, Li You, Xu Wang, Kamil Musílek, Yingying Zhao and Jiajia Zhang. Their work appears in journals such as Food and Chemical Toxicology, European Journal of Medicinal Chemistry and Ecotoxicology and Environmental Safety.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026